CervoMed Inc.·4

Nov 17, 9:01 AM ET

ALAM JOHN J 4

4 · CervoMed Inc. · Filed Nov 17, 2025

Insider Transaction Report

Form 4
Period: 2025-11-13
ALAM JOHN J
DirectorCEO & President10% Owner
Transactions
  • Purchase

    Common Stock

    2025-11-13$7.51/sh+4,447$33,3971,471,578 total
  • Purchase

    Common Stock

    2025-11-14$7.55/sh+1,693$12,7821,473,271 total
  • Purchase

    Common Stock

    2025-11-14$7.57/sh+1,707$12,9221,707 total(indirect: By Spouse)
Footnotes (4)
  • [F1]Shares purchased in open-market transactions.
  • [F2]Includes 1,471,578 shares held jointly by the Reporting Person and his spouse, Dr. Sylvie Gregoire, PharmD., a member of the Issuer's Board of Directors.
  • [F3]Includes 1,693 shares held by the John J. Alam Roth IRA. The price reported is a weighted average price. The shares were purchased in open-market transactions at prices ranging from $7.41 to $7.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full detail regarding the number of shares purchased at each separate price within such range.
  • [F4]Includes 1,707 shares held by the Sylvie Gregoire Roth IRA. The price reported is a weighted average price. The shares were purchased in open-market transactions at prices ranging from $7.44 to $7.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full detail regarding the number of shares purchased at each separate price within such range.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4